You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 14, 2024

DrugPatentWatch Database Updates: New Patent Delistings


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch Database Updates: New Patent Delistings

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Usecode Patented / Exclusive Use
Merck Sharp Dohme WELIREG belzutifan TABLET 215383 Aug 13, 2021 RX Yes ⤷  Sign Up ⤷  Sign Up U-3201 TREATMENT OF ADULT PATIENTS WITH VON HIPPEL-LINDAU DISEASE WHO REQUIRE THERAPY FOR ASSOCIATED RENAL CELL CARCINOMA, CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS, OR PANCREATIC NEUROENDOCRINE TUMORS, NOT REQUIRING IMMEDIATE SURGERY
Merck Sharp Dohme WELIREG belzutifan TABLET 215383 Aug 13, 2021 RX Yes ⤷  Sign Up ⤷  Sign Up U-3780 TREATMENT OF ADULT PATIENTS WITH ADVANCED RENAL CELL CARCINOMA FOLLOWING A PROGRAMMED DEATH RECEPTOR-1 OR PROGRAMMED DEATH-LIGAND INHIBITOR AND A VASCULAR ENDOTHELIAL GROWTH FACTOR TYROSINE KINASE INHIBITOR
Amarin Pharms VASCEPA icosapent ethyl CAPSULE 202057 Jul 26, 2012 RX Yes ⤷  Sign Up ⤷  Sign Up U-1287 METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA
Amarin Pharms VASCEPA icosapent ethyl CAPSULE 202057 Feb 16, 2017 RX Yes ⤷  Sign Up ⤷  Sign Up U-1287 METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Patent Expiration >Usecode >Patented / Exclusive Use

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.